Hidron, AI, Edwards, JR, Patel, J, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:996–1011. Erratum in Infect Control Hosp Epidemiol 2009;30:107.
Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:1–14.
Weiner, LM, Webb, AK, Limbago, B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol 2016;37:1288–1301.
Urinary tract infection (catheter-associated urinary tract infection [CAUTI] and non-catheter-associated urinary tract infection [UTI]) and other urinary system infection [USI]) events. Centers for Disease Control and Prevention (CDC) website. http://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf. Updated January 2019. Accessed June 3, 2019.
Hocevar, SN, Weiner, LM, Edwards, JR, Magill, SS. Pathogen distribution and selected resistance profiles of central line-associated bloodstream infection isolates reported to the National Healthcare Safety Network from pediatric and neonatal intensive care units, 2011–2013. In: Program and abstracts of the annual IDWeek Meeting; October 8–12, 2014; Philadelphia, PA. Abstract no. 45238.
Lake, JG, Weiner, LM, Milstone, AM, Saiman, L, Magill, SS, See, I. Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the National Healthcare Safety Network, 2011–2014. Infect Control Hosp Epidemiol 2017;39:1–11.
Weiner-Lastinger, LM, Abner, S, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with pediatric healthcare-associated infections: summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol 2019. https://doi.org/10.1017/ice.2019.297. 14.
The 2015–2017 adult antimicrobial resistance report online supplement. Centers for Disease Control and Prevention (CDC) website. https://www.cdc.gov/nhsn/datastat/index.html. Updated September 2019. Accessed October 14, 2019.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. Wayne, PA: CLSI; 2017: M100-S27.
Systematized Nomenclature of Medicine–Clinical Terms (SNOMED CT) Browser: United States edition. SNOMED International website. https://browser.ihtsdotools.org Updated 2019. Accessed June 4, 2019.
Tindall, BJ, Sutton, G, Garrity, GM.
Enterobacter aerogenes Hormaeche and Edwards 1960 (Approved Lists 1980) and Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980) share the same nomenclature type (ATCC 13048) on the approved lists and are homotypic synonyms, with consequences for the name Klebsiella mobilis Bascomb et al. 1971 (Approved Lists 1980). Int J Syst Evol Microbiol 2017;67:502–504.
Magiorakos, A-P, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268–281.
See, I, Freifeld, AG, Magill, SS. Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009–2012. Clin Infect Dis 2016;62:1203–1209.
McKinnell, JA, Singh, RD, Miller, LG, et al. The SHIELD Orange County Project—multi drug-resistant organism (MDRO) prevalence in 21 nursing homes and long-term acute-care facilities in southern California. Clin Infect Dis 2019;ciz119:1–8.
Munoz-Price, LS, Stemer, A. Four years of surveillance cultures at a long-term acute-care hospital. Infect Control Hosp Epidemiol 2010;31:59–63.
Woodworth, KR, Walters, MS, Weiner, LM, et al. Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms—United States, 2006–2017. Morb Mortal Wkly Rep 2018;67:396–401.
Weiner, LM, Fridkin, SK, Aponte-Torres, Z, et al. Vital signs: preventing antibiotic-resistant infections in hospitals—United States, 2014. Morb Mortal Wkly Rep 2016;65:235–241.
Slayton, RB, Toth, D, Lee, BY, et al. Vital signs: estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities—United States. Morb Mortal Wkly Rep 2015;64:826–831.
Campoccia, D, Montanaro, L, Arciola, CR. The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 2006;27:2331–2339.
Owens, CD, Stoessel, K. Surgical site infections: epidemiology, microbiology, and prevention. J Hosp Infect 2008;70:3–10.
Archibald, L, Phillips, L, Monnet, D, McGowan, JE Jr, Tenover, F, Gaynes, R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211–215.
Fridkin, SK, Edwards, JR, Tenover, FC, Gaynes, RP, McGowan, JE Jr. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001;33:324–329.
Streit, JM, Jones, RN, Sader, HS, Fritsche, TR. Assessment of pathogen occurrences and resistance profiles among infection patients in the intensive care unit: report from the SENTRY antimicrobial surveillance program (North America, 2001). Int J Antimicrob Agents 2004;24:111–118.
Pappas, PG, Kauffman, CA, Andes, DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62:e1–e50.